48 results
Page 2 of 3
8-K
EX-99.1
5m8kvguv50
22 Oct 20
Regulation FD Disclosure
1:14pm
8-K
EX-99.2
491 l0obn
7 May 20
Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
8:10am
8-K
EX-99.1
t20dhcqif0jmy
9 Sep 19
Other Events
12:00am
8-K
EX-99.1
v7xvlmf5v5kdp
27 Jun 19
Regulation FD Disclosure
12:04pm
8-K
EX-99.1
n3xavj4 f0gq
6 Dec 18
Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome
8:05am
8-K
EX-99.1
a3lqll01nwn9 5hw
25 Oct 18
Regulation FD Disclosure
10:25am
8-K
EX-99.2
4g9b byx3s
25 Oct 18
Regulation FD Disclosure
10:25am